Disease intervention and vaccines research at UTSA includes research on developing vaccines and advancing drug discovery and development against bacterial, fungal, viral, parasitic, and immune-mediated diseases.
A major area of research focus is on developing vaccines and therapeutics against biothreat agents (Biodefense) to mitigate attacks due to accidental or deliberate release of pathogens with the intention of causing harm to humans, animals, or plants. Two Biosafety Level 3 laboratories are available for performing studies related to Biodefense at UTSA. Texas Biomedical Research Institute has several Biosafety Level 3 and Level 4 laboratories for study of highly infectious pathogens using a number of non-human primate models of infection.
Drug discovery and development to treat infectious and non-infectious diseases is another major area of research focus at UTSA with a large cohort of investigators with a wide range of scientific expertise, in areas of chemistry, genomics, microbiology, parasitology, pharmacology, and virology, among others. Currently, a large number of studies are directed at identifying novel compounds from drug libraries, de novo discovery or synthesis of new chemical compounds and repurposing of existing drugs for treatment of infectious and non-infectious diseases.
Participating Faculty
UTSA Faculty
